HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 179 filers reported holding HERON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.57 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $118,000 | -63.7% | 20,600 | -7.0% | 0.00% | -83.3% |
Q2 2020 | $325,000 | +8025.0% | 22,146 | +7282.0% | 0.02% | – |
Q1 2020 | $4,000 | -42.9% | 300 | +2.0% | 0.00% | – |
Q4 2019 | $7,000 | +250.0% | 294 | +143.0% | 0.00% | – |
Q2 2019 | $2,000 | -99.1% | 121 | -98.7% | 0.00% | -100.0% |
Q1 2019 | $221,000 | -72.1% | 9,051 | -63.8% | 0.01% | -73.9% |
Q3 2018 | $791,000 | -39.7% | 24,986 | -26.0% | 0.05% | -44.6% |
Q2 2018 | $1,311,000 | +16.1% | 33,748 | -17.5% | 0.08% | +1.2% |
Q1 2018 | $1,129,000 | +19.6% | 40,910 | -21.6% | 0.08% | +7.9% |
Q4 2017 | $944,000 | +53.7% | 52,163 | +37.1% | 0.08% | +38.2% |
Q3 2017 | $614,000 | +1705.9% | 38,043 | +1802.2% | 0.06% | +1275.0% |
Q3 2016 | $34,000 | -62.2% | 2,000 | -57.9% | 0.00% | -69.2% |
Q1 2016 | $90,000 | +4400.0% | 4,747 | +4647.0% | 0.01% | – |
Q3 2015 | $2,000 | -60.0% | 100 | -75.0% | 0.00% | -100.0% |
Q2 2014 | $5,000 | – | 400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |